Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
PHIOW was delisted on the 21st of December, 2021.
2 hedge funds and large institutions have $4K invested in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
0% more capital invested
Capital invested by funds: $4K → $4K ($0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.32K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
+$132 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $4K | +$1.32K | +7,022 | +40% |
|
|
2
Osaic Holdings
Scottsdale,
Arizona
| – | +$132 | +700 | +23% |
|
PHIOW Hedge Fund Activity: Q3 2020 in Review
2 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) for Q3 2020, worth a combined $4K — unchanged from a quarter earlier.
Fund positioning in PHIOW was balanced in Q3 2020: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $1.32K.
- 2 institutional investors held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $4K of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 stock for Q3 2020, unchanged quarter-over-quarter.
- 0 funds opened new Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 positions in Q3 2020 and 0 closed out.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 buyer in Q3 2020 was Susquehanna International Group, an estimated $1.32K added.
Based on aggregated 13F filings for Q3 2020.